GLP-1 also slows down how fast your stomach empties, making you feel full for a longer period
Andrews said the case report, along with other observational data involving ALS patients with diabetes, suggests healthcare providers should carefully consider the risks and benefits before prescribing GLP-1 medications to people with underlying neurodegenerative conditions
I didnt have to figure it out while feeling awful. -Jennifer K., 38, completed 48-week trial successfully Month 2: Peak Side Effects (Weeks 5-8) This is the hardest month
Zepbound was approved by the FDA in November 2023 for chronic weight management in adults with obesity as well as those who are overweight and have at least one weight-related condition like high blood pressure or high cholesterol
The researchers found that the condition was associated with enhanced polyp detection but not increased diagnosis of colorectal cancer
Diabetes platforms without meaningful weight loss or systemic metabolic impact are structurally weakened